Alcon Inc. Share Price

Equities

ALC

CH0432492467

Medical Equipment, Supplies & Distribution

Market Closed - Swiss Exchange 09:01:30 26/04/2024 pm IST 5-day change 1st Jan Change
72 CHF +0.61% Intraday chart for Alcon Inc. -0.66% +9.69%

Financials

Sales 2024 * 10B 9.14B 834B Sales 2025 * 10.65B 9.73B 888B Capitalization 38.82B 35.46B 3,237B
Net income 2024 * 936M 855M 78.04B Net income 2025 * 1.26B 1.15B 105B EV / Sales 2024 * 4.18 x
Net Debt 2024 * 2.95B 2.69B 246B Net Debt 2025 * 1.76B 1.6B 146B EV / Sales 2025 * 3.81 x
P/E ratio 2024 *
43.2 x
P/E ratio 2025 *
33.3 x
Employees 25,315
Yield 2024 *
0.37%
Yield 2025 *
0.44%
Free-Float 98.58%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.61%
1 week-0.66%
Current month-3.67%
1 month-4.28%
3 months+8.53%
6 months+14.03%
Current year+9.69%
More quotes
1 week
71.40
Extreme 71.4
74.14
1 month
71.18
Extreme 71.18
76.98
Current year
62.24
Extreme 62.24
77.60
1 year
61.28
Extreme 61.28
77.60
3 years
55.22
Extreme 55.22
81.40
5 years
38.63
Extreme 38.625
81.40
10 years
38.63
Extreme 38.625
81.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 01/16/01
Director of Finance/CFO 56 08/19/08
Chief Tech/Sci/R&D Officer - 01/11/01
Members of the board TitleAgeSince
Chairman 68 01/18/01
Director/Board Member 65 01/19/01
Director/Board Member 60 01/19/01
More insiders
Date Price Change Volume
26/24/26 72 +0.61% 766,855
25/24/25 71.56 -1.70% 664,229
24/24/24 72.8 -1.33% 643,532
23/24/23 73.78 +0.79% 781,654
22/24/22 73.2 +0.99% 713,956

Delayed Quote Swiss Exchange, April 26, 2024 at 09:01 pm IST

More quotes
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
78.71 USD
Average target price
93.32 USD
Spread / Average Target
+18.56%
Consensus